<?xml version="1.0" encoding="UTF-8"?>
<p>In December 2019, reports of a novel coronavirus, since named SARS‐CoV‐2, emerged from Wuhan, central Hubei Province, China.
 <xref rid="apt15779-bib-0001" ref-type="ref">
  <sup>1</sup>
 </xref>, 
 <xref rid="apt15779-bib-0002" ref-type="ref">
  <sup>2</sup>
 </xref>, 
 <xref rid="apt15779-bib-0003" ref-type="ref">
  <sup>3</sup>
 </xref> The virus causes the disease COVID‐19, which manifests as a severe acute respiratory illness that can be complicated by acute respiratory distress syndrome (ARDS), multiorgan failure and even death.
 <xref rid="apt15779-bib-0003" ref-type="ref">
  <sup>3</sup>
 </xref> Following rapid spread of the virus across the globe, the World Health Organisation (WHO) declared COVID‐19 a pandemic on 11 March 2020.
 <xref rid="apt15779-bib-0002" ref-type="ref">
  <sup>2</sup>
 </xref> There are currently almost 2 million confirmed cases across more than 200 countries with a total death count greater than 100 000 at the time of writing.
 <xref rid="apt15779-bib-0002" ref-type="ref">
  <sup>2</sup>
 </xref> As the pandemic expands, there has been increasing concern regarding the impact of COVID‐19 on patients with IBD.
</p>
